Cargando…

Non-Dexamethasone Corticosteroid Therapy’s Effect on COVID-19 Prognosis in Cancer Patients: A Retrospective Study

Background: Anti-inflammatory corticosteroids are used in cancer treatment and COVID-19 infections. Data on the impact of non-dexamethasone corticosteroids on COVID-19 infection severity in cancer patients are minimal. This study investigates if corticosteroid treatment affects the disease severity...

Descripción completa

Detalles Bibliográficos
Autores principales:	Souan, Lina, Al-Khairy, Zienab, Battah, Abdelkader, Sughayer, Maher A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9964883/ https://www.ncbi.nlm.nih.gov/pubmed/36851168 http://dx.doi.org/10.3390/vaccines11020290

Ejemplares similares

The Effect of Dexamethasone Treatment on COVID-19 Prognosis in Cancer Patients
por: Souan, Lina, et al.
Publicado: (2022)

COVID-19 Antibody Seroconversion in Cancer Patients: Impact of Therapy Cessation—A Single-Center Study
por: Souan, Lina, et al.
Publicado: (2023)

Comparative Assessment of the Kinetics of Cellular and Humoral Immune Responses to COVID-19 Vaccination in Cancer Patients
por: Souan, Lina, et al.
Publicado: (2023)

An update on the impact of SARS-CoV-2 pandemic public awareness on cancer patients' COVID-19 vaccine compliance: Outcomes and recommendations
por: Souan, Lina, et al.
Publicado: (2022)

Changing trends in seroprevalence rates of transfusion-transmitted diseases among blood donors in Jordan
por: Souan, Lina, et al.
Publicado: (2021)

Dramatic rise in seroprevalence rates of SARS-CoV-2 antibodies among healthy blood donors: The evolution of a pandemic
por: Sughayer, Maher A., et al.
Publicado: (2021)

Comparison of the Immunogenicity and Protective Efficacy of Various SARS-CoV-2 Vaccines among Healthcare Workers: Are Our White Coat Armies Protected?
por: Souan, Lina, et al.
Publicado: (2022)

The Use of the Anticoagulant Heparin and Corticosteroid Dexamethasone as Prominent Treatments for COVID-19
por: Braz-de-Melo, Heloísa Antoniella, et al.
Publicado: (2021)

DEXAMETHASONE: CHONDROPROTECTIVE CORTICOSTEROID OR CATABOLIC KILLER?
por: Black, R., et al.
Publicado: (2019)

The prognosis and short-term efficacy of corticosteroid therapy for COVID-19 patients
por: Jia, Xinyu, et al.
Publicado: (2021)

Comparison of the effectiveness and duration of anti-RBD SARS-CoV-2 IgG antibody response between different types of vaccines: Implications for vaccine strategies
por: Sughayer, M.A., et al.
Publicado: (2022)

Anaplastic lymphoma kinase rearrangements in patients with non-small cell lung cancer in Jordan
por: Maraqa, Bayan, et al.
Publicado: (2022)

Prevalence and clinicopathological associations of HER2 expression in non-small cell lung cancer: a retrospective study in Jordanian patients
por: Abu Al Karsaneh, Ola, et al.
Publicado: (2023)

Outcomes associated with tocilizumab with or without corticosteroid versus dexamethasone for treatment of patients with severe to critical COVID-19 pneumonia
por: AlQahtani, Hajar, et al.
Publicado: (2022)

Efficacy of Additional Corticosteroids After Dexamethasone Treatment for Moderate to Severe COVID-19: An Observational Study
por: Fukuda, Yosuke, et al.
Publicado: (2023)

The impact of COVID-19 pandemic on medical students’ mental health and sleep quality in Jordan: a nationwide cross-sectional study
por: Alnaser, Adnan Raed, et al.
Publicado: (2021)

Corticosteroid Therapy in Optic Neuropathy Secondary to Nasopharyngeal Carcinoma
por: Wahab, Zulaikha, et al.
Publicado: (2021)

THE EFFICACY OF REMDESIVIR WITH DEXAMETHASONE VS. DEXAMETHASONE ALONE IN ADULTS HOSPITALIZED WITH COVID-19: A RETROSPECTIVE COHORT STUDY
por: AL-MISTAREHI, ABDEL-HAMEED, et al.
Publicado: (2022)

Dexamethasone: a corticosteroid drug for the treatment of coronavirus disease 2019
por: Riaz, Muhammad, et al.
Publicado: (2022)

Factors that predict severity of infection and seroconversion in immunocompromised children and adolescents with COVID-19 infection
por: Abu Shanap, Mayada, et al.
Publicado: (2022)

Corticosteroid therapy in critically ill patients with COVID-19: a multicenter, retrospective study
por: Li, Yiming, et al.
Publicado: (2020)

Baricitinib plus dexamethasone compared to dexamethasone for the treatment of severe COVID-19 pneumonia: A retrospective analysis
por: Pérez-Alba, Eduardo, et al.
Publicado: (2021)

Comparison of corticosteroids types, dexamethasone, and methylprednisolone in patients hospitalized with COVID-19: A systematic review and network meta-analysis
por: Morsali, Mina, et al.
Publicado: (2023)

Dexamethasone or methylprednisolone therapy in covid-19 pneumonia: A retrospective and comparative study of 513 cases
por: El mezzeoui, Sanae, et al.
Publicado: (2021)

Corticosteroid therapy in patients with heart failure hospitalized for COVID-19: a multicenter retrospective study
por: Pérez-Belmonte, Luis M., et al.
Publicado: (2021)

Effectiveness of adjunctive corticosteroid therapy in patients with severe COVID-19: A retrospective cohort study
por: Xiong, Bin, et al.
Publicado: (2021)

Corticosteroids for Non-severe COVID-19: Primum Non Nocere
por: Muthu, Valliappan, et al.
Publicado: (2022)

Low Incidence of the DPD IVS14+1G>A Polymorphism in Jordanian Breast and Colorectal Cancer patients
por: Al-Khateeb, Mohammad, et al.
Publicado: (2017)

Pros and cons of corticosteroid therapy for COVID-19 patients
por: Mattos-Silva, Paula, et al.
Publicado: (2020)

Corticosteroids for COVID-19 Therapy: Potential Implications on Tuberculosis
por: Gopalaswamy, Radha, et al.
Publicado: (2021)

Corticosteroids for COVID-19: the search for an optimum duration of therapy
por: Mishra, Gyanshankar P, et al.
Publicado: (2021)

Comparative outcomes of combined corticosteroid and remdesivir therapy with corticosteroid monotherapy in ventilated COVID-19 patients
por: Mandadi, Subhadra, et al.
Publicado: (2022)

Corticosteroids for COVID-19
por: Annane, Djillali
Publicado: (2021)

A Retrospective Study of Dexamethasone, Remdesivir, and Baricitinib in Severe COVID-19
por: Ngo, Dallis Q., et al.
Publicado: (2022)

Ciprofloxacin/corticosteroids/dexamethasone: Lack of efficacy and off-label use: case report
Publicado: (2022)

Antibacterials/corticosteroids/dexamethasone: Lack of efficacy and off-label use: case report
Publicado: (2021)

COVID-19 and corticosteroids: a narrative review
por: El-Saber Batiha, Gaber, et al.
Publicado: (2022)

Methylprednisolone or dexamethasone, which one is superior corticosteroid in the treatment of hospitalized COVID-19 patients: a triple-blinded randomized controlled trial
por: Ranjbar, Keivan, et al.
Publicado: (2021)

Anakinra or high-dose corticosteroids in COVID-19 pneumonia patients who deteriorate on low-dose dexamethasone: an observational study of comparative effectiveness
por: Langer-Gould, Annette, et al.
Publicado: (2023)

Molecular determinants of vascular transport of dexamethasone in COVID-19 therapy
por: Shabalin, Ivan G., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_2k0mlvudfl8kbahc7mr5bj0gui